A randomized trial assessing the effect of coumarins started before coronary angioplasty on restenosis: Results of the 6-month angiographic substudy of the Balloon Angioplasty and Anticoagulation Study (BAAS)

American Heart Journal

Volumn 145, Issue 1, 2003, Pages 58-65

  Ten Berg, Jurriën M ^a   Kelder, Johannes C ^a   Suttorp, Maarten Jan ^a   Verheugt, Freek W A ^b   Plokker, H W Thijs ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN ANTICOAGULANT; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS;

EID: 0037217717     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.63     Document Type: Article

References (23)

1. Serruys PW, van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin-coated stents with ballóon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673-81.
2. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll of Cardiol 1992;20:1284-93.
3. Willerson JT. Stent restenosis: Can effective antithrombotic therapy be protective? Circulation 1997;96:383-5.
4. Ip JH, Fuster V, Israel D, et al. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll of Cardiol 1991;17:77-88B.
5. Willerson JT, Yao SK, McNatt J, et al. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA 1991;88:10624-8.
6. White JC, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk: Angioscopy as a clinical tool. Circulation 1996;93:253-8.
7. Heijer den P, Foley DP, Escaned J, et al. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll of Cardiol 1994;24:649-54.
8. ten Berg JM, Kelder JC, Suttorp MJ, et al. Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: A randomized trial. Circulation 2000;102;386-91.
9. Reiber JHC. An overview of coronary quantitation techniques as of 1989. In: Reiber JHC, Serruys PW, editors. Quantitative Coronary Arteriography. Dordrecht: Kluwer Academic Publishers; 1991. p. 55-132.
10. Gallo R, Padurean A, Toschi V, et al. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 1998;97:581-8.
11. Thome LM, Gimple LW, Bachluber BG, et al. Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone. Circulation 1998;98:2301-6.
12. Gerdes C, Faber-Steinfeld V, Yalkinoglu O, et al. Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointima formation after arterial injury. Arterios Thromb Vasc Biol 1996;16:1306-11.
13. Topol EJ, Califf M, Weisman HF, et al. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994;343:881-6.
14. Violaris AG, Melkert R, Herrman J-P R, et al. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty. Circulation 1996;93:889-97.
15. Thornton MA, Gruentzig AR, Hollman J, et al. Coumadin and ASA in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 1984;69:721-7.
16. Urban P, Buller N, Fox K, et al. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 1988;60:485-8.
17. Serruys PW, Herrman JP, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995;333:757-63.
18. Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-9.
19. Kastrati A, Schühlen H, Hausleiter J, et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: Six-month angiographic follow-up of the intracoronary stenting and antithrombotic regimen (ISAR) trial. Circulation 1997;96:462-7.
20. Garachemani AR, Fielsch M, Ehrhard K, et al. Restenosis is not reduced by antithrombotic therapy after PTCA: A randomized angiographic follow-up study. J Am Coll Cardiol 1999;(Suppl A): 1158-94.
21. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-8.
22. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coranary artery disease and the acute coronary syndromes. N Eng J Med 1992;326:242-50.
23. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Eng J Med 1992;326:310-8.